[Prion-like Propagation Model of Tau]

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Abnormal tau and α-synuclein proteins aggregate in dementia, exhibiting prion-like propagation.
• Existing mouse models show limited human tau expression, hindering accurate pathogenesis studies.
• Understanding tau propagation is crucial for developing effective dementia therapies.

Purpose of the Study:

• To create a novel mouse model with human-like tau expression patterns for studying dementia.
• To investigate the propagation mechanisms of abnormal tau protein in the brain.
• To explore novel therapeutic strategies for dementia based on inhibiting abnormal protein spread.

Main Methods:

• Genome editing was used to develop a mouse model with human-like tau expression.
• Sarkosyl-insoluble fractions containing abnormal tau from human tauopathy patients were inoculated into the mouse brain.
• Histochemical and neuronal circuitry analyses were performed to map tau pathology accumulation and propagation.

Main Results:

• The novel mouse model successfully replicated human-like tau expression patterns.
• Inoculation with patient-derived tau induced abnormal tau accumulation and pathology.
• Detailed analysis elucidated the relationship between inoculation sites and subsequent tau pathology spread, revealing propagation pathways.

Conclusions:

• The developed mouse model accurately mimics human tauopathy, offering a valuable platform for dementia research.
• The study provides insights into the mechanisms of abnormal tau propagation in the brain.
• This research supports the development of novel dementia treatments focused on inhibiting the spread of toxic proteins.